Coronavirus News and Research

RSS

Antiviral activity of favipiravir against Zika and SARS-CoV-2 in cynomolgus macaques

A new study determines the antiviral efficacy of favipiravir against ZIKV and SARS-CoV-2 infections.

4 Sep 2022

MHRA approves bivalent COVID-19 booster vaccine made by Pfizer/BioNTech

A second, "bivalent" vaccine has today been approved as a booster by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

3 Sep 2022

Covid-19 study highlights a continued drop in U.S. life expectancy

An updated analysis of American COVID-19 deaths throughout 2021 highlights a continued drop in overall life expectancy as well as persistent disparities by race and ethnicity.

2 Sep 2022

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

Millions of people have died of coronavirus infection since 2020 because influential institutions took too long to recognize that it is primarily airborne, and a new University of Colorado Boulder-led historical analysis sheds light on the delay.

2 Sep 2022

How does ACE2 expression in target cells affect neutralization by antibodies to different spike epitopes?

Researchers evaluated how ACE2 expression in target cells impacts neutralization.

2 Sep 2022

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Researchers summarized existing data on the immunogenicity of COVID-19 vaccines and the humoral and cellular immune responses against SARS-CoV-2.

2 Sep 2022

What is the risk of BA.5 infection among persons with documented infection with past variants?

A recent correspondence discussed a study in which researchers assessed the infection risk for the SARS-CoV-2 Omicron BA.5 subvariant in vaccinated people exposed to previous SARS-CoV-2 variants.

2 Sep 2022

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

Researchers presented findings from the second version of a living systematic review on long COVID.

2 Sep 2022

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

2 Sep 2022

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

Researchers assessed the impact of COVID-19 infection on B-cell and antibody responses to COVID-19 booster vaccination.

2 Sep 2022

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

In a recent JAMA Pediatrics study, scientists analyzed a cohort containing children and adolescents after recovering from COVID-19 to determine the dynamics of neutralizing antibodies.

2 Sep 2022

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

A recent PLoS ONE study detected neutralizing nanobodies against SARS-CoV-2 from nanobody phage display libraries and via in vitro and ex vivo high-throughput screenings.

2 Sep 2022

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

In a new study, researchers illustrated that metformin was associated with decreased coronavirus disease 2019 (COVID-19) severity among prediabetic patients.

1 Sep 2022

What is the influence of individual infectiousness variation on COVID-19 spread across households?

In a new study, scientists characterized the effect of individual infectiousness variance on the transmission heterogeneity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among households.

1 Sep 2022

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

The current study focused on the ability of this nmAb to neutralize Delta, Omicron, and other VOCs, as well as its efficacy when given by the intranasal route in an animal model.

1 Sep 2022

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

In a new study, researchers assessed the effects of N501Y mutation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein on binding to angiotensin-converting enzyme-2 (ACE-2).

1 Sep 2022

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

Can SARS-CoV-2 transmission occur from an infected dead body?

In new research, researchers determined whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be transmitted from a dead body.

1 Sep 2022

Scientists develop a novel solution to evaluate airborne transmission of SARS-CoV-2

Scientists from Germany have developed a novel mathematical model to study the airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Aug 2022

Analysis of the seasonality of common human coronaviruses

A new study published in the Emerging Infectious Diseases journal aimed to analyze the circulation of four common HCoVs from July 2014 to November 2021 in the US.

31 Aug 2022

Coronavirus News and Research

Antiviral activity of favipiravir against Zika and SARS-CoV-2 in cynomolgus macaques

MHRA approves bivalent COVID-19 booster vaccine made by Pfizer/BioNTech

Covid-19 study highlights a continued drop in U.S. life expectancy

Analysis sheds light on the delay to recognize airborne transmission of the coronavirus

How does ACE2 expression in target cells affect neutralization by antibodies to different spike epitopes?

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

What is the risk of BA.5 infection among persons with documented infection with past variants?

First update of living systematic review provides a comprehensive summary of studies on the risk of experiencing long COVID

The origins, breadth, and resolution of autoreactivity in severe COVID-19

The effects of SARS-CoV-2 infection on antibody and B-cell responses to a third dose of mRNA vaccination

The dynamics of neutralizing antibodies in a cohort of children and adolescents after SARS-CoV-2 infection

A rapid and efficient method of identifying neutralizing nanobodies directed against SARS-CoV-2

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

What is the influence of individual infectiousness variation on COVID-19 spread across households?

Intranasally delivered neutralizing antibody protects against SARS-CoV-2 Omicron and Delta variants

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

How does origin impact antiviral immune response?

Can SARS-CoV-2 transmission occur from an infected dead body?

Scientists develop a novel solution to evaluate airborne transmission of SARS-CoV-2

Analysis of the seasonality of common human coronaviruses

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News